Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

Completed · Phase 4

Conditions studied: Nausea, Vomiting, Satisfaction

In brief

The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that receive just acupressure point P6 stimulation.

Key facts

Study ID

NCT02960113

Run by

Rutgers, The State University of New Jersey

People needed

240

Starts

2016-05-01

Expected to finish

2021-09-01

Last updated by the study team

2022-12-28

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female subjects ages 18 to 45
• Subjects with ASA Class I or II
• Subjects with elective primary or repeat cesarean delivery
• Subjects who receive spinal and/or epidural anesthesia
• English and non-English speaking subjects will be included in the study

You may not qualify if…

• Female subjects <18 years of age
• Subjects requiring emergent cesarean delivery
• Gestational age < 37 weeks
• History of placenta accreta
• Multiple gestation pregnancy
• ASA status III or higher
• Current history of pregnancy induced hypertension, pre-eclampsia, or eclampsia
• History of any chronic medication use (other than prenatal vitamins), including inhaler medications
• Current urinary tract infection, pneumonia, or otitis media
• Coagulopathies or skin infections overlying the spine
• History of open angle glaucoma, seizures or psychosis

Where it is running

• Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.